Department of Hematologic Oncology, Levine Cancer Institute, USA
Perspective Article The use of genomic and prothrombotic biomarkers in the treatment of cancer offers a wide range of potential outcomes. Author(s): Maria Blackburn*
DOI: 10.35841/2472-1646.23.09.034
HTML PDF
Biomarkers Journal received 253 citations as per Google Scholar report